Search for: "CIPLA LIMITED"
Results 1 - 20
of 51
Sorted by Relevance
|
Sort by Date
13 Feb 2014, 9:04 am
Indianapolis, Indiana - Indiana patent lawyers for Alcon Research, LTD of Fort Worth, Texas and Alcon Pharmaceuticals Ltd of Fribourg, Switzerland (collectively, "Alcon") sued in the Southern District of Indiana alleging that Cipla Limited of Mumbai Central, Mumbai and Cipla USA Inc. of Miami, Florida (collectively, "Cipla") infringed Olopatadine Formulations for Topical Administration, Patent Nos. 6,995,186 (the "'186 patent") and 7,402,609 (the "'609 patent"),… [read post]
4 Jun 2012, 3:00 am
The contempt citation read on Cipla, which the defendants said limited its activities of a joint venture in India. [read post]
21 Nov 2020, 7:54 am
Cipla Limited, et al., Civil Action No. 18-192-CFC/CJB (D.Del. [read post]
31 Oct 2016, 11:33 am
This federal lawsuit, commenced in the Southern District of Indiana, lists two Defendants, Cipla Limited of Mumbai, India and its wholly owned subsidiary Cipla USA, Inc. of Miami, Florida. [read post]
31 May 2012, 9:00 pm
Merial Limited, BASF Agro B.V. v. [read post]
14 Mar 2017, 1:59 am
The plaintiff, Cipla Limited (CL) is a well-known Indian pharma company, while the defendant, Cipla Industries Pvt Ltd (CIPL), runs a business in varied household goods. [read post]
21 Mar 2017, 11:45 pm
Kat konfusion regarding passing off: likelihood of confusion and the Starbucks (HK) caseIPKat Neil Wilkof muses about the complexity of the three requirements of passing off and the issue of likelihood of confusion as they played out in the UKSC’s Starbucks (HK) decision.Thursday ThingiesThis Kitten reports forthcoming events in Bournemouth (3D Printing), Budapest, Minnesota, Basel and Geneva.Wednesday WhimsiesInternKat Hayleigh Bosher summarizes IP news and events including an IP Ball.First… [read post]
31 Dec 2012, 1:52 pm
Cipla patent infringement suit was India’s first pharmaceutical patent litigation in the Post TRIPS era. [read post]
14 Jun 2012, 10:00 pm
Cipla Limited. [read post]
21 Sep 2010, 7:47 pm
– Peanut based malnutrition treatment – humanitarian developments and compulsory licensing (IP finance) NGOs warn on IP in Trans Pacific Trade Agreement (IP Watch) Africa: African traditional knowledge and folklore given IP protection despite warning of TK commodification (IP Watch) Brazil, EU, India, Netherlands: Consultations on WTO drug transit case continue (IP Watch) EU: Vaccines causing trouble once more… Georgetown University referral to ECJ concerning SPC Regulation (The… [read post]
15 Jan 2013, 11:49 am
Cipla has always been appealing to the Indian government to modify its intellectual property laws to safeguard Indian consumers from monopoly. [read post]
18 Feb 2013, 12:46 am
Yusuf Hamied is the Chairman of Cipla and, is also known as the Grand Old Man of the Indian Pharmaceuticals Industry. [read post]
7 May 2021, 6:25 am
Murali Neelakantan - Principal Lawyer, Amicus and former Global General Counsel, Cipla Limited The panellists for Session I are: 1. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]
11 Mar 2015, 9:15 am
They do not like change and hesitate to expose their clients to the uncertain risks of an ADR process of which they have limited awareness. [read post]
12 Feb 2010, 6:55 am
“The U.S. would grant a patent to a piece of toilet paper,” says Amar Lulla, chief executive of Cipla, the Indian generics drugmaker. [read post]
18 Aug 2010, 12:19 am
Apotex Pty Ltd; CSL Limited v. [read post]
11 Feb 2013, 7:40 pm
Cipla for one continues to manufacture generic equivalents of Sorafenib despite a valid patent held by Bayer. [read post]
14 Mar 2012, 6:40 am
The patentee is Bayer Corporation, and the applicant for an compulsory license is Natco Pharma Limited, an Indian generic pharmaceuticals company. [read post]
10 Feb 2010, 4:47 pm
Schmeiser (IP Osgoode) Canada: Doctrine of sound prediction and the case of Apotex Inc v Wellcome Foundation Ltd (IP Osgoode) Chile Industrial Association of Pharmaceutical Laboratories (Asilfa) responds to the American Chamber of Commerce allegations of copying certain American laboratories medicines (IP tango) China: Higher People’s Court of Beijing recognizes novelty in dosage limitations in Swiss-Form claims (Patents4Life) EU: EPO: More about Alice – Pelargonium extract… [read post]
